Inspira to Unveil HYLA™ Real-Time Blood Sensor at U.S. ELSO; 97.35% Accuracy Confirmed - Inspira Technologies Oxy (NASDAQ:IINN)

Core Insights - Inspira Technologies is set to unveil its HYLA blood sensor at the ELSO Annual Conference, marking its first presentation to the global medical community [1][2] - The HYLA sensor has demonstrated a performance accuracy of 97.35% compared to standard blood gas analyzers, positioning it as a significant advancement in medical technology [2] - The ELSO conference serves as a strategic platform for Inspira to engage with key opinion leaders and potential commercial partners [3][4] Company Overview - Inspira Technologies specializes in advanced respiratory support and real-time blood monitoring solutions, with its ART100 system cleared by the FDA for cardiopulmonary bypass and ECMO procedures [5] - The company is developing the next-generation ART500 system, which aims to provide oxygenation while patients remain awake and breathing spontaneously [5] - Inspira is advancing its proprietary HYLA blood sensor platform for continuous, non-invasive monitoring, enhancing its position in the life-support and MedTech landscape [5]